Vivimed Labs Board of Directors

Get the latest insights into the leadership at Vivimed Labs. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dr. Manohar Rao Varalwar Chairman & Wholetime Director
Mr. Santosh Varalwar Managing Director
Mr. Sandeep Varalwar Whole Time Director
Ms. Aparna Bidarkar Independent Director
Ms. Subbarathnamma Palepu Independent Director
Mr. Jarugula Siva Prasad Independent Director

Vivimed Labs Share price

VIVIMEDLAB

26.6

0 (0.00%)
NSE
BSE
Last updated on 18 Dec, 2025 | 15:49 IST
alert_iconwatchlist_icon
BUYSELL
Today's High

29.40

Today's Low

26.60

52 Week Low

0.00

52 Week High

29.40

alert_iconThe current prices are delayed, login to your account for live prices

Vivimed Labs FAQs

The board at Vivimed Labs consists of experienced professionals, including Dr. Manohar Rao Varalwar , Mr. Santosh Varalwar , and others, overseeing the company’s strategic and corporate governance.

Directors at Vivimed Labs are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dr. Manohar Rao Varalwar is the current chairman at Vivimed Labs.

Executive directors at Vivimed Labs are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Vivimed Labs adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Vivimed Labs, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.